I
Intensity Therapeutics Inc
NASDAQ:INTS
Intensity Therapeutics Inc
NASDAQ:INTS
Price:
4
USD
Market Closed
Market Cap:
$10.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
I
|
Intensity Therapeutics Inc
NASDAQ:INTS
|
US |
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0 | 0 | |
| (6.2m) | (8m) | (7.6m) | (8.3m) | (16.6m) | (12m) | |
| (1.2m) | (2.2m) | (2.4m) | (3.5m) | (6.1m) | (5.2m) | |
| (5.1m) | (5.9m) | (5.1m) | (4.8m) | (10.5m) | (6.8m) | |
| (6.2m) | (8m) | (7.6m) | (8.3m) | (16.6m) | (12m) | |
| 74k | 2.6k | (80k) | 19k | 314k | 180k | |
| — | — | 82k | 305k | — | — | |
| — | — | 0 | (2.3m) | 0 | — | |
| 118.8k | 115.5k | 48k | 24k | 3k | 186k | |
| (6m) | (7.9m) | (7.6m) | (10.5m) | (16.3m) | (11.6m) | |
| — | — | — | — | 0 | — | |
| (6m) | (7.9m) | (7.6m) | (10.5m) | (16.3m) | (11.6m) | |
| (6m) | (7.9m) | (7.6m) | (11.9m) | (16.3m) | (11.6m) | |
| (11.50) | (15.06) | (14.47) | (21.63) | (29.24) | (8.56) |
A cash-generative biotech transitioning from legacy MS to acquired growth platforms
A rapidly scaled RNAi platform moving from R&D losses to product profitability
A global oncology platform moving from costly R&D expansion toward scalable profitability
